Puzzlingly, inhibition of NHE1 with several inhibitors did not prevent the migration of prostate cancer cells, and it appears that some other physiological roles of NHE1 are important in this cell type, rather than NHE1 activity itself. The gene discussed is SLC9A1; the disease is prostate carcinoma.